These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2278510)

  • 21. Why aluminum phosphate is less toxic than aluminum hydroxide.
    Berthon G; Daydé S
    J Am Coll Nutr; 1992 Jun; 11(3):340-8. PubMed ID: 1619187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part I: composition and structure.
    Burrell LS; Johnston CT; Schulze D; Klein J; White JL; Hem SL
    Vaccine; 2000 Sep; 19(2-3):275-81. PubMed ID: 10930682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
    Hem SL; White JL; Buehler JD; Luber JR; Grim WM; Lipka EA
    Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removal of coagulant aluminum from water treatment residuals by acid.
    Okuda T; Nishijima W; Sugimoto M; Saka N; Nakai S; Tanabe K; Ito J; Takenaka K; Okada M
    Water Res; 2014 Sep; 60():75-81. PubMed ID: 24835954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of gastrointestinal absorption or urinary excretion of aluminium from an allantoinate complex contained in two antacid formulations in patients with normal renal function.
    Guillard O; Huguet F; Fauconneau B; Piriou A; Pineau A
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):609-12. PubMed ID: 8877335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
    Levesque PM; de Alwis U
    Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineral-metabolic side effects of low-dose antacids.
    Weberg R; Berstad A; Aaseth J; Falch JA
    Scand J Gastroenterol; 1985 Aug; 20(6):741-6. PubMed ID: 4035293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric mucosal calcinosis. Calcified aluminum phosphate deposits secondary to aluminum-containing antacids or sucralfate therapy in organ transplant patients.
    Greenson JK; Trinidad SB; Pfeil SA; Brainard JA; McBride PT; Colijn HO; Tesi RJ; Lucas JG
    Am J Surg Pathol; 1993 Jan; 17(1):45-50. PubMed ID: 8447508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical reactivity of aluminium-based pharmaceutical compounds used as phosphate-binders.
    Cargill RW; Dutkowskij M; Prescott A; Fleming LW; Stewart WK
    J Pharm Pharmacol; 1989 Jan; 41(1):11-6. PubMed ID: 2565957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective removal of Pb2+ by AlPO4.
    Naeem A; Mustafa S; Rehana N; Dilara B; Murtaza S
    Environ Technol; 2003 Jun; 24(6):779-85. PubMed ID: 12868533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of neutralizing properties of antacid preparations. Part 7. 27Al NMR studies of aluminum species formed during acid dissolution of some antacid preparations.
    Kokot Z
    Pharmazie; 1989 Dec; 44(12):828-30. PubMed ID: 2635320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of myo-inositol hexakisphosphate sorption on amorphous aluminum hydroxide: spectroscopic evidence for rapid surface precipitation.
    Yan Y; Li W; Yang J; Zheng A; Liu F; Feng X; Sparks DL
    Environ Sci Technol; 2014 Jun; 48(12):6735-42. PubMed ID: 24871399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CONTROL of the corrosion factor in peptic ulcer; a report on the efficacy of dihydroxy aluminum aminoacetate (alglyn N.N.R.) as a gastric antacid.
    J Fla Med Assoc; 1951 Sep; 38(3):200. PubMed ID: 14861397
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of an aluminum-magnesium containing antacid and gastric mucus: possible contribution to the cytoprotective function of antacids.
    Grübel P; Bhaskar KR; Cave DR; Garik P; Stanley HE; Lamont JT
    Aliment Pharmacol Ther; 1997 Feb; 11(1):139-45. PubMed ID: 9042986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants.
    al-Shakhshir R; Regnier F; White JL; Hem SL
    Vaccine; 1994 Apr; 12(5):472-4. PubMed ID: 8023556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.
    Shi Y; HogenEsch H; Hem SL
    Vaccine; 2001 Oct; 20(1-2):80-5. PubMed ID: 11567749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orthophosphate and metaphosphate ion removal from aqueous solution using alum and aluminum hydroxide.
    Georgantas DA; Grigoropoulou HP
    J Colloid Interface Sci; 2007 Nov; 315(1):70-9. PubMed ID: 17692328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum aluminium levels of intensive care patients treated with two different antacids for prevention of stress ulceration.
    Rauch H; Fleischer F; Böhrer H; Jürs G; Wilhelm M; Krier C
    Intensive Care Med; 1989; 15(2):84-6. PubMed ID: 2785545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adsorption of phosphate from aqueous solution by hydroxy-aluminum, hydroxy-iron and hydroxy-iron-aluminum pillared bentonites.
    Yan LG; Xu YY; Yu HQ; Xin XD; Wei Q; Du B
    J Hazard Mater; 2010 Jul; 179(1-3):244-50. PubMed ID: 20334967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
    DePaz RA; Henderson I; Advant SJ
    Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.